PLoS ONE (Jan 2022)

Longitudinal serologic and viral testing post-SARS-CoV-2 infection and post-receipt of mRNA COVID-19 vaccine in a nursing home cohort-Georgia, October 2020‒April 2021.

  • Farrell A Tobolowsky,
  • Michelle A Waltenburg,
  • Erin D Moritz,
  • Melia Haile,
  • Juliana C DaSilva,
  • Amy J Schuh,
  • Natalie J Thornburg,
  • Adrianna Westbrook,
  • Susannah L McKay,
  • Stephen P LaVoie,
  • Jennifer M Folster,
  • Jennifer L Harcourt,
  • Azaibi Tamin,
  • Megan M Stumpf,
  • Lisa Mills,
  • Brandi Freeman,
  • Sandra Lester,
  • Elizabeth Beshearse,
  • Kristin D Lecy,
  • Laura G Brown,
  • Geroncio Fajardo,
  • Jeanne Negley,
  • L Clifford McDonald,
  • Preeta K Kutty,
  • Allison C Brown,
  • CDC Infection Prevention and Control Team

DOI
https://doi.org/10.1371/journal.pone.0275718
Journal volume & issue
Vol. 17, no. 10
p. e0275718

Abstract

Read online

There are limited data describing SARS-CoV-2-specific immune responses and their durability following infection and vaccination in nursing home residents. We conducted a prospective longitudinal evaluation of 11 consenting SARS-CoV-2-positive nursing home residents to evaluate the quantitative titers and durability of binding antibodies detected after SARS-CoV-2 infection and subsequent COVID-19 vaccination. The evaluation included nine visits over 150 days from October 25, 2020, through April 1, 2021. Visits included questionnaire administration, blood collection for serology, and paired anterior nasal specimen collection for testing by BinaxNOW™ COVID-19 Ag Card (BinaxNOW), reverse transcription polymerase chain reaction (RT-PCR), and viral culture. We evaluated quantitative titers of binding SARS-CoV-2 antibodies post-infection and post-vaccination (beginning after the first dose of the primary series). The median age among participants was 74 years; one participant was immunocompromised. Of 10 participants with post-infection serology results, 9 (90%) had detectable Pan-Ig, IgG, and IgA antibodies, and 8 (80%) had detectable IgM antibodies. At first antibody detection post-infection, two-thirds (6/9, 67%) of participants were RT-PCR-positive, but none were culture- positive. Ten participants received vaccination; all had detectable Pan-Ig, IgG, and IgA antibodies through their final observation ≤90 days post-first dose. Post-vaccination geometric means of IgG titers were 10-200-fold higher than post-infection. Nursing home residents in this cohort mounted robust immune responses to SARS-CoV-2 post-infection and post-vaccination. The augmented antibody responses post-vaccination are potential indicators of enhanced protection that vaccination may confer on previously infected nursing home residents.